background
sever
pneumonia
respons
great
mortal
morbid
worldwid
earlyappli
effect
antiinfect
therapi
improv
prognosi
patient
howev
identif
infecti
agent
sever
pneumonia
remain
major
challeng
far
studi
potenti
util
transmiss
electron
microscopi
tem
detect
nonbacteri
pathogen
patient
sever
pneumonia
retrospect
evalu
materi
method
total
patient
diagnos
sever
pneumonia
hospit
septemb
decemb
includ
baselin
clinic
characterist
collect
nonbacteri
infecti
agent
detect
tem
bronchoalveolar
lavag
fluid
balf
serolog
test
summar
detect
rate
compar
tem
serolog
test
result
balf
examin
transmiss
electron
microscop
reveal
virus
mycoplasma
chlamydia
fungi
bacteria
sampl
among
sampl
mix
infect
combin
use
serolog
test
tem
significantli
improv
detect
rate
nonbacteri
infecti
agent
patient
sever
pneumonia
conclus
data
support
implement
tem
could
improv
sensit
detect
virus
atyp
pathogen
mix
infect
balf
patient
sever
pneumonia
therefor
tem
may
use
auxiliari
diagnost
method
microbiolog
test
sever
pneumonia
introduct
p
neumonia
affect
approxim
million
peopl
global
caus
nearli
million
death
year
sever
pneumonia
common
reason
intens
care
unit
admiss
repres
major
concern
physician
due
high
mortal
rate
without
appropri
treatment
rapidli
progress
respiratori
failur
septic
shock
even
caus
death
within
sever
day
earli
etiolog
diagnosi
would
facilit
prompt
initi
antiinfect
therapi
critic
improv
clinic
outcom
patient
sever
pneumonia
sever
pneumonia
may
bacteri
viral
fungal
atyp
etiolog
includ
mycoplasma
pneumonia
chlamydia
pneumonia
legionella
pneumophila
identif
caus
agent
sever
nonbacteri
pneumonia
challeng
microbiolog
cultur
lower
respiratori
tract
specimen
blood
lung
tissu
consid
gold
standard
etiolog
diagnosi
pneumonia
howev
virus
atyp
pathogen
cultur
analysi
rare
use
due
delay
result
complic
procedur
serolog
test
polymeras
chain
reaction
pcr
target
specif
pathogen
routin
deploy
clinic
use
limit
identifi
novel
rare
pathogen
mix
infect
report
caus
agent
confirm
nearli
half
pneumonia
episod
despit
care
test
thu
antiinfect
therapi
empir
appli
base
clinic
featur
thorac
imag
earli
stage
pneumonia
may
increas
rate
treatment
failur
caus
drugrel
toxic
therefor
urgent
need
develop
comprehens
assay
system
prompt
etiolog
diagnosi
sever
pneumonia
transmiss
electron
microscopi
tem
use
diagnost
microbiolog
sinc
profound
impact
knowledg
understand
microorgan
tem
wellrecogn
use
tool
rapid
morpholog
identif
infecti
agent
emerg
situat
infecti
diseas
unknown
caus
potenti
diagnost
valu
nonbacteri
etiolog
sever
pneumonia
remain
unexplor
yet
bronchoalveolar
lavag
common
method
obtain
valid
sampl
lower
respiratori
tract
bronchoalveolar
lavag
fluid
balf
advantag
improv
detect
etiolog
agent
communityacquir
pneumonia
suitabl
multipl
detect
method
includ
microscop
therefor
studi
retrospect
analyz
potenti
diagnost
valu
tem
examin
balf
sampl
sever
pneumonia
retrospect
review
medic
record
made
patient
diagnos
sever
pneumonia
treat
xiangya
hospit
central
south
univers
changsha
hunan
china
septemb
decemb
diagnosi
sever
pneumonia
made
accord
infecti
diseas
societi
america
american
societi
microbiolog
criteria
major
criteria
includ
requir
mechan
ventil
need
vasopressor
minor
criteria
list
follow
bun
mgdl
confus
disorient
hypotens
requir
aggress
fluid
resuscit
hypothermia
core
temperatur
f
leukopenia
white
blood
cell
count
per
mm
multilobar
infiltr
pao
fio
ratio
respiratori
rate
breathsminut
thrombocytopenia
platelet
count
per
mm
patient
met
least
major
criterion
minor
criteria
diagnos
sever
pneumonia
balf
sampl
patient
fail
initi
antiinfect
treatment
examin
tem
patient
exclud
newborn
never
left
hospit
tem
examin
serolog
test
perform
total
patient
includ
studi
bronchoalveolar
lavag
perform
within
hour
patient
admiss
flexibl
bronchoscopi
local
anesthesia
lidocain
singlecent
xiangya
hospit
set
use
standard
method
briefli
sampl
area
select
base
infiltr
locat
chest
radiograph
three
ml
fraction
steril
salin
instil
relev
lobe
segment
lung
balf
retriev
gentl
syring
suction
put
steril
contain
immedi
submit
depart
patholog
tem
examin
tem
examin
balf
perform
depart
patholog
xiangya
hospit
balf
centrifug
rpm
minut
supernat
remov
subsequ
pellet
remain
bottom
tube
centrifug
fix
glutaraldehyd
osmium
tetroxid
dehydr
grade
seri
aceton
embed
mixtur
epon
substitut
araldit
total
thin
section
nm
sampl
stain
uranyl
acet
reynold
lead
citrat
imag
perform
kv
use
hitachi
transmiss
electron
microscop
hitachi
tokyo
japan
digit
imag
specimen
acquir
use
amt
advantag
xr
ccd
camera
amt
danver
analyz
experienc
electron
microscopist
total
hour
need
tem
examin
batch
balf
sampl
serolog
test
perform
depart
clinic
laboratori
xiangya
hospit
serum
sampl
collect
patient
antibiot
treatment
within
hour
hospit
admiss
feasibl
depend
patient
situat
serum
immunoglobulin
ig
antibodi
specif
common
pathogen
respiratori
tract
includ
adenoviru
respiratori
syncyti
viru
influenza
b
viru
influenza
viru
human
parainfluenza
virus
pneumonia
c
pneumonia
l
pneumophila
coxiella
burneti
detect
use
indirect
immunofluoresc
assay
mcnemar
test
perform
compar
detect
rate
differ
diagnost
method
statist
analys
carri
use
spss
statist
version
ibm
corpor
armonk
ny
p
valu
consid
statist
signific
ensur
qualiti
report
result
present
studi
recommend
guidelin
base
criteria
publish
standard
report
diagnost
accuraci
initi
accur
report
investig
diagnost
studi
follow
baselin
characterist
patient
includ
studi
summar
tabl
eightyon
patient
male
older
year
age
fortyeight
patient
smoke
histori
common
clinic
manifest
patient
includ
fever
cough
dyspnea
consolid
ground
glass
opac
pleural
effus
frequent
found
comput
tomographi
scan
durat
hospit
stay
patient
progress
acut
respiratori
distress
syndrom
patient
usual
complic
chronic
renal
failur
heart
diseas
hypertens
total
patient
receiv
antibiot
admiss
hospit
averag
length
hospit
stay
day
rang
day
patient
got
significantli
reliev
discharg
hospit
comprehens
therapi
work
remain
patient
repres
transmiss
electron
micrograph
imag
pathogen
balf
shown
figur
figur
includ
viru
chlamydia
mycoplasma
fungu
coccu
bacillu
gener
categori
pathogen
determin
accord
size
shape
characterist
structur
exampl
virus
diamet
nm
main
morpholog
viru
type
includ
helic
icosahedr
envelop
complex
symmetr
virus
mycoplasma
mollicut
genu
bacteria
lack
cell
wall
around
cell
membran
diamet
nm
chlamydia
genu
pathogen
bacteria
oblig
intracellular
parasit
may
found
form
elementari
bodi
reticul
bodi
besid
fungi
usual
grow
hypha
cylindr
threadlik
structur
mm
diamet
sever
centimet
length
fungi
also
dispers
spore
sporecontain
propagul
reproduct
purpos
total
tem
examin
balf
reveal
virusposit
sampl
mycoplasmaposit
sampl
chlamydiaposit
sampl
fungusposit
sampl
bacteriumposit
sampl
pathogen
remain
sampl
detect
total
sampl
found
mix
infect
tem
tabl
total
bacteria
sampl
identifi
bacteri
cultur
analys
lower
respiratori
tract
specimen
among
sampl
mix
infect
tabl
even
though
tem
show
higher
detect
rate
bacteria
cultur
could
differenti
bacteri
strain
provid
inform
antibiot
sensit
thu
littl
diagnost
valu
detect
bacteria
balf
nonbacteri
pathogen
virus
pneumonia
c
pneumonia
l
pneumophila
identifi
routin
cultur
method
specif
isol
cultur
test
laborintens
timeconsum
rare
use
hospit
etiolog
diagnosi
instead
pathogenspecif
igm
antibodi
serum
consid
significantli
indic
routin
measur
clinic
suspicion
infect
pathogen
shown
tabl
tem
examin
balf
success
confirm
pathogenposit
sampl
indic
serolog
test
includ
viru
mycoplasma
chlamydia
strikingli
tem
also
detect
infecti
agent
number
sampl
patient
report
neg
result
serolog
test
tabl
investig
whether
applic
tem
could
facilit
etiolog
diagnosi
sever
pneumonia
compar
pathogen
detect
rate
serolog
test
tem
reveal
detect
rate
tem
significantli
higher
serolog
test
tabl
furthermor
number
sampl
confirm
pathogenposit
markedli
increas
combin
serolog
test
tem
tabl
identif
infecti
agent
challeng
patient
sever
pneumonia
present
studi
found
tem
good
detect
nonbacteri
pathogen
balf
obtain
patient
sever
pneumonia
implement
tem
could
significantli
improv
diagnost
sensit
nonbacteri
etiolog
best
knowledg
first
retrospect
studi
report
use
tem
etiolog
diagnosi
sever
pneumonia
sever
pneumonia
lifethreaten
without
clear
indic
caus
agent
antibiot
treatment
usual
determin
empir
may
caus
sever
drug
resist
higher
cost
increas
mortal
risk
therefor
microbiolog
test
strongli
recommend
patient
sever
pneumonia
probabl
chang
empir
treatment
high
reduc
treatment
failur
prevent
antibiot
overus
gold
standard
etiolog
diagnosi
microbiolog
cultur
effici
sever
pneumonia
due
timeconsum
procedur
high
incid
fals
neg
result
importantli
cultur
analysi
rare
use
detect
virus
atyp
pathogen
due
delay
result
complic
procedur
pcr
serolog
test
popular
due
highspe
capac
process
larg
quantiti
sampl
time
howev
suitabl
detect
novelrar
pathogen
mix
infect
therefor
addit
techniqu
could
facilit
etiolog
diagnosi
sever
pneumonia
urgent
need
especi
initi
empir
antiinfect
therapi
fail
present
studi
data
demonstr
tem
good
sensit
detect
nonbacteri
infecti
agent
balf
combin
use
serolog
test
tem
improv
detect
rate
nonbacteri
pathogen
furthermor
report
mix
infect
defin
least
type
pathogen
contain
sampl
occur
half
case
communityacquir
pneumonia
associ
sever
inflammatori
disord
interestingli
base
data
tem
appear
far
sensit
detect
mix
infect
compar
serolog
test
spite
combin
detect
modal
overal
rate
treatment
failur
studi
thought
caus
sever
system
complic
antibiot
resist
tem
wide
use
diagnost
microbiolog
decad
even
though
clinic
use
tem
gradual
declin
popular
molecular
immunolog
techniqu
offer
signific
advantag
detect
virus
atyp
pathogen
capac
detect
multipl
pathogen
present
within
sampl
singl
test
moreov
tem
examin
balf
sampl
take
hour
mean
clinic
physician
could
get
fast
inform
kind
infecti
agent
exist
lung
patient
unlik
serolog
test
pcr
tem
requir
organismspecif
reagent
detect
pathogen
howev
sever
drawback
tem
techniqu
first
sampl
must
process
individu
tem
examin
lead
low
throughput
field
view
tem
also
rel
small
increas
possibl
region
analyz
may
repres
whole
sampl
could
caus
fals
neg
result
addit
accuraci
tem
examin
depend
skill
experi
microscopist
thu
studi
experienc
electron
microscopist
involv
imag
analysi
sampl
avoid
misdiagnosi
furthermor
diagnost
valu
tem
bacteri
pneumonia
limit
routin
tem
differenti
bacteri
strain
provid
inform
antibiot
sensit
thu
benefit
subsequ
antibiot
therapi
far
advanc
electron
microscopi
em
techniqu
appli
microbiolog
basic
clinic
studi
includ
cryogen
electron
tomographi
immunoem
em
correl
light
microscopi
tem
tem
integr
immunohistochemistri
molecular
label
techniqu
would
becom
practic
electron
microscopist
clinic
physician
distinguish
variou
pathogen
strain
level
tem
recent
rapid
method
sampl
prepar
transport
em
equip
make
em
easier
faster
tool
use
also
report
improv
identif
infecti
agent
studi
data
collect
support
futur
tem
may
use
along
diagnost
tool
one
part
comprehens
assay
system
microbiolog
diagnosi
sever
pneumonia
sever
imit
note
present
studi
first
balf
sampl
healthi
volunt
subject
obtain
made
diagnost
specif
tem
unevalu
interpret
tem
examin
difficult
plan
address
futur
studi
addit
major
disadvantag
tem
use
studi
identifi
pathogen
strain
level
hope
applic
advanc
techniqu
combin
use
microbi
test
would
enhanc
diagnost
accuraci
tem
thu
improv
diagnost
valu
moreov
even
though
tem
examin
balf
appear
potenti
util
improv
diagnost
sensit
sever
pneumonia
caus
nonbacteri
pathogen
costeffect
still
unknown
therefor
clinic
trial
larg
patient
number
must
conduct
determin
whether
implement
tem
could
benefit
patient
sever
pneumonia
promot
prompt
initi
antiinfect
treatment
summari
data
support
tem
good
sensit
detect
nonbacteri
pathogen
balf
includ
virus
atyp
pathogen
mix
infect
combin
use
serolog
test
tem
could
improv
detect
rate
nonbacteri
infecti
agent
patient
sever
pneumonia
consid
sever
rapid
progress
sever
pneumonia
singl
diagnost
method
recommend
case
implement
tem
would
judici
strategi
etiolog
diagnosi
sever
pneumonia
caus
nonbacteri
pathogen
futur
